<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0B5C4660-E127-4BC5-A05F-FFEE95EED6F1"><gtr:id>0B5C4660-E127-4BC5-A05F-FFEE95EED6F1</gtr:id><gtr:name>The interNational Early Onset Paediatric IBD Cohort Study (NEOPICS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/132225E8-29CD-4330-8185-C1A2A3699111"><gtr:id>132225E8-29CD-4330-8185-C1A2A3699111</gtr:id><gtr:name>Raigmore Hospital</gtr:name><gtr:address><gtr:line1>Old Perth Road</gtr:line1><gtr:postCode>IV2 3UJ</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/73F10E86-681D-4A3F-8193-FD194CB47AC5"><gtr:id>73F10E86-681D-4A3F-8193-FD194CB47AC5</gtr:id><gtr:name>NIHR CRN staff and facilities throughout the UK</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/41B8ED11-2F70-499F-B830-E858F69FB414"><gtr:id>41B8ED11-2F70-499F-B830-E858F69FB414</gtr:id><gtr:name>?rebro University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E55B119-02E7-43F3-9B39-DD48A6511372"><gtr:id>4E55B119-02E7-43F3-9B39-DD48A6511372</gtr:id><gtr:name>Addenbrooke's Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Centre for Molecular Medicine</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0B5C4660-E127-4BC5-A05F-FFEE95EED6F1"><gtr:id>0B5C4660-E127-4BC5-A05F-FFEE95EED6F1</gtr:id><gtr:name>The interNational Early Onset Paediatric IBD Cohort Study (NEOPICS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/132225E8-29CD-4330-8185-C1A2A3699111"><gtr:id>132225E8-29CD-4330-8185-C1A2A3699111</gtr:id><gtr:name>Raigmore Hospital</gtr:name><gtr:address><gtr:line1>Old Perth Road</gtr:line1><gtr:postCode>IV2 3UJ</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/73F10E86-681D-4A3F-8193-FD194CB47AC5"><gtr:id>73F10E86-681D-4A3F-8193-FD194CB47AC5</gtr:id><gtr:name>NIHR CRN staff and facilities throughout the UK</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/41B8ED11-2F70-499F-B830-E858F69FB414"><gtr:id>41B8ED11-2F70-499F-B830-E858F69FB414</gtr:id><gtr:name>?rebro University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E55B119-02E7-43F3-9B39-DD48A6511372"><gtr:id>4E55B119-02E7-43F3-9B39-DD48A6511372</gtr:id><gtr:name>Addenbrooke's Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6F95777A-5C1B-4D68-992A-C70F70D9860F"><gtr:id>6F95777A-5C1B-4D68-992A-C70F70D9860F</gtr:id><gtr:firstName>Craig</gtr:firstName><gtr:surname>Stevens</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/EF904DB6-0838-427D-A513-EBFD09816648"><gtr:id>EF904DB6-0838-427D-A513-EBFD09816648</gtr:id><gtr:firstName>Ted</gtr:firstName><gtr:surname>Hupp</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/89BA485B-7769-4A31-9B5A-33FC964268AB"><gtr:id>89BA485B-7769-4A31-9B5A-33FC964268AB</gtr:id><gtr:firstName>Jack</gtr:firstName><gtr:surname>Satsangi</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/16E0A6F0-8F3A-4615-813F-2D07843468C4"><gtr:id>16E0A6F0-8F3A-4615-813F-2D07843468C4</gtr:id><gtr:firstName>Marian</gtr:firstName><gtr:surname>Aldhous</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0A1BB275-37CE-4752-AAAE-6803B7847BA2"><gtr:id>0A1BB275-37CE-4752-AAAE-6803B7847BA2</gtr:id><gtr:firstName>Elaine</gtr:firstName><gtr:surname>Nimmo</gtr:surname><gtr:orcidId>0000-0002-9301-9901</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800759"><gtr:id>4C7E0831-049C-4A8E-96CB-45EFB43D9652</gtr:id><gtr:title>Evaluating the importance of autophagy/xenophagy in protecting the intestinal epithelium in Crohn s Disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800759</gtr:grantReference><gtr:abstractText>The inflammatory bowel diseases (IBD) are disabling life-long illnesses which are common in the Western world. Typical symptoms common to both illnesses include abdominal pain, weight loss, and diarrhoea. There are two main types of inflammatory bowel disease: Crohn?s disease (CD) and ulcerative colitis (UC). The cause of these illnesses is not certain, but it is now very clear that each condition is influenced by a number of genetic risk factors as well as environmental factors. These include the presence of bacteria in the bowel and smoking habit. Recently, great progress has been made in identifying several new genetic risk factors involved in Crohn?s disease. Two of the most recently identified genes are involved in a process called autophagy, a mechanism by which cells conserve or recycle specific proteins to keep themselves alive in conditions of starvation, or under specific environmental ?stressors?. There is some evidence that autophagy might also be involved in the maintenance of a healthy gut, removing or killing ?bad? bacteria and allowing ?good? bacteria to live there. Changes in the regulation of the autophagy pathway might upset this delicate balance or allow ?good? bacteria to produce unwanted responses from the gut cells, leading to inflammation. In a series of laboratory experiments, we aim to investigate this pathway and to clarify how function is changed in CD patients and the effect of different environmental ?stressors?, and of genetic alterations. Results will indicate whether this pathway is involved in the cause or development of CD and may also indicate the molecular pathways involved which could potentially lead to the development of new drug therapy.</gtr:abstractText><gtr:technicalSummary>The inflammatory bowel diseases (IBD), Crohn?s disease (CD) and ulcerative colitis (UC) are common causes of gastro-intestinal morbidity in UK, affecting 1 in 250 individuals. Over the last decade there has been striking progress in the understanding of mechanisms of pathogenesis of IBD with many insights from human genetics and genetically-engineered animal models. Focus has moved from the specific immune response towards evaluation of the innate intestinal response in the gastro-intestinal tract with the identification in 2001 of NOD2, an intracellular receptor for muramyl dipeptide, as the first susceptibility gene in CD.
Most recently, several other susceptibility genes for CD have been identified in genome-wide association studies (GWAS) including two genes, ATG16L1 and IRGM, which are involved in autophagy. These discoveries provide the catalyst for the present study; to examine this pathway in CD, and specifically to examine its importance and relevance to the innate immune response in the intestinal epithelium in CD. Autophagy represents a homeostatic mechanism for the removal and turnover of proteins and organelles via the lysosome, as well as an adaptive response to starvation to provide an energy source to maintain cell viability. In addition, autophagy provides defence against specific intracellular bacteria, which are engulfed by autophagosomes and transferred to lysosomes for degradation, a process now known as xenophagy.
In our initial studies, we aim to define the pattern of dysregulation of autophagy/xenophagy characteristic of CD and to identify molecular mechanisms involved. We shall evaluate intestinal biopsies and peripheral blood from CD patients, and controls using available assays. 
We shall then explore the relationship between autophagy and NOD2 signalling pathways both in cell lines and in short?term organ culture of intestinal biopsies, thereby building on genetic data implying epistatic interaction and preliminary data that we have generated, which suggest CD-associated NOD2 variation may affect autophagolysosome stability. We shall explore functional consequences of the disease-associated ATG16L1 gene mutation on protein-protein interactions involved in autophagosome formation and stability and on NOD2 gene and protein expression and downstream effects of NFkB activation, defensin, and chemokine synthesis/secretion. 
 To assess gene-environmental interactions, we shall explore whether pathogen-associated motifs (LPS, MDP or PG) or cigarette smoke constituents affect autophagy pathways and ATG16L1/IRGM gene expression in cell lines and ex vivo organ culture).
Finally we shall address specifically whether dysregulated autophagy allows survival of entero-invasive E. coli strains, now strongly associated with CD, in the intestinal epithelium.</gtr:technicalSummary><gtr:fund><gtr:end>2012-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>330036</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Aberdeen</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Rowett Institute of Nutrition and Health Aberdeen</gtr:department><gtr:description>Collaboration with Dr Georgina Hold in Aberdeen</gtr:description><gtr:id>5B8E37FA-F6CF-478D-BC82-7E7A6EA3859E</gtr:id><gtr:impact>Work is still underway. At this stage, there is an accepted poster presentation at ECCO, Vienna Feburary 2013, and plans for a paper to be submitted in the next couple of months. There will be further publications and conference abstracts as well.</gtr:impact><gtr:outcomeId>DUNVuyF7tYv-2</gtr:outcomeId><gtr:partnerContribution>Dr Georgina Hold (IMS) and Dr Petra Louis (Rowett) have provided expertise, training and the use of equipment for the studies of the microbiota.</gtr:partnerContribution><gtr:piContribution>We have collected colonic and ileal biopsies over the past 18 months for study of the microbial profile in patients with inflammatory bowel disease and controls. Dr Nick Kennedy has travelled to Aberdeen to extract the DNA from the biopsies and to perform qPCR.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Paediatric IBD departments</gtr:department><gtr:description>UK and Irish Paediatric IBD genetics group</gtr:description><gtr:id>76075A06-F046-4C9E-A60E-7860E2336AA6</gtr:id><gtr:impact>First experiment underway - 650 of 720 PICTS DNA samples submitted for international immunochip experiment; data collection commenced in collaborating centres; Analysis underway, 1st abstract published, 1st manuscript submitted 11/2011 to Nature Genetics.</gtr:impact><gtr:outcomeId>VdXmJKskAX5-1</gtr:outcomeId><gtr:partnerContribution>They will widen translational paediatric IBD research from Scotland to 6 selected centres in England plus Dublin, Ireland</gtr:partnerContribution><gtr:piContribution>I am lead of this UK and Irish paediatric IBD genetics group, a new constituent part of the UK IBD genetics consortium, and have attracted external funding as PI to form the paediatric group.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Aberdeen</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Health Services Research Unit</gtr:department><gtr:description>Collaboration with Dr Georgina Hold in Aberdeen</gtr:description><gtr:id>112946C6-A02F-4874-B342-46F1C02FE662</gtr:id><gtr:impact>Work is still underway. At this stage, there is an accepted poster presentation at ECCO, Vienna Feburary 2013, and plans for a paper to be submitted in the next couple of months. There will be further publications and conference abstracts as well.</gtr:impact><gtr:outcomeId>DUNVuyF7tYv-1</gtr:outcomeId><gtr:partnerContribution>Dr Georgina Hold (IMS) and Dr Petra Louis (Rowett) have provided expertise, training and the use of equipment for the studies of the microbiota.</gtr:partnerContribution><gtr:piContribution>We have collected colonic and ileal biopsies over the past 18 months for study of the microbial profile in patients with inflammatory bowel disease and controls. Dr Nick Kennedy has travelled to Aberdeen to extract the DNA from the biopsies and to perform qPCR.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NIHR CRN Staff and Facilities Throughout the UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>EXPANSION INTO ENGLAND AND WALES</gtr:description><gtr:id>1827D957-F4B1-4E95-A182-D08E92EDBC43</gtr:id><gtr:impact>RESTORATION OF RECRUITMENT RATES TO THOSE EXPECTED.</gtr:impact><gtr:outcomeId>JZoW174pja8-1</gtr:outcomeId><gtr:partnerContribution>RECRUITMENT EXPANSION TO ENGLAND AND WALES.</gtr:partnerContribution><gtr:piContribution>RECRUITMENT EXPANSION INTO ENGLAND AND WALES AS A RESULT OF OUR INVITATION TO 20 OTHER UK CENTRES TO PARTICIPATE</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The interNational Early Onset Paediatric IBD Cohort Study (NEOPICS)</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>NEOPICS</gtr:description><gtr:id>83DA62A1-3675-481B-AACA-9F217C714F03</gtr:id><gtr:impact>Multidisciplinary - laboratory, translational and clinical colleagues.

Publication - HH Uhlig, T Schwerd, S Koletzko, N Shah, J Kammermeier, A Elkadri, J Ouahed, DC Wilson, S Travis, D Turner, C Klein, SB Snapper, AM Muise. Very early onset inflammatory bowel disease - diagnostic approach to complex monogenic diseases. Gastroenterology 2014 (in press).

Meeting - participation by Prof DC Wilson at 'VEOIBD 2014' meeting, Toronto, 16/10/14</gtr:impact><gtr:outcomeId>5464c65e28c398.89430129-1</gtr:outcomeId><gtr:partnerContribution>Ongoing genomic, pathway and functional analysis of VEOIBD p[atients.</gtr:partnerContribution><gtr:piContribution>Provision of clinical, phenotypic data and DNA on very-early onset IBD patients (VEOIBD; &amp;lt;10 years old at diagnosis)</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Addenbrooke's Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>International IBD genetics consortium</gtr:description><gtr:id>892020A6-BB47-4965-AE01-D7C95E86635A</gtr:id><gtr:impact>2 publications, further published abstracts:

A Franke, , DPB McGovern, JC Barrett, K Wang, GL Radford-Smith, T Ahmad, CW Lees, T Balschun, J Lee, R Roberts, CA Anderson, JC Bis, S Bumpstead, D Ellinghaus, EM Festen, M Georges, T Green, T Haritunians, L Jostins, A Latiano, CG Mathew, GW Montgomery, NJ Prescott, S Raychaudhuri, JI Rotter, P Schumm, Y Sharma, LA Simms, KD Taylor, D Whiteman, C Wijmenga, RN Baldassano, M Barclay, TM Bayless, S Brand, C B&amp;uuml;ning, A Cohen, J-F Colombel, M Cottone, L Stronati, T Denson, M De Vos, R D'Inca, M Dubinsky, C Edwards, T Florin, D Franchimont, RGearry, J Glas, A Van Gossum, SL Guthery, J Halfvarson, HW Verspaget, J-P Hugot, A Karban, D Laukens, I Lawrance, M Lemann, A Levine, C Libioulle, E Louis, C Mowat, W Newman, J Pan&amp;eacute;s, A Phillips, DD Proctor, M Regueiro, R Russell, P Rutgeerts, J Sanderson, M Sans, FSeibold, AH Steinhart, PCF Stokkers, LTorkvist, G Kullak-Ublick, DC Wilson, T Walters, SR Targan, SR Brant, JD Rioux, M D'Amato, RK Weersma, S Kugathasan, AM Griffiths, JC Mansfield, S Vermeire, RH Duerr, MS Silverberg, J Satsangi, S Schreiber, JH Cho, V Annese, H Hakonarson, MJ Daly, M Parkes. Meta-Analysis Increases to 71 the Tally of Confirmed Crohn's Disease Susceptibility Loci. Nature Genetics 2010; 42: 1118-25 

Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, Lagace C, Scott R, Amininejad L, Bumpstead S, Baidoo L, Baldassano RN, Barclay M, Bayless TM, Brand S, Buning C, Colombel JF, Denson LA, de Vos M, Dubinsky M, Edwards C, Ellinghaus D, Fehrmann RSN, Floyd JAB, Florin T, Franchimont D, Franke L, Georges M, Glas J, Glazer NL, Guthery SL, Haritunians T, Hayward NK, Hugot JP, Jobin G, Laukens D, Lawrance I, Lemann M, Levine A, Libioulle C, Louis E, McGovern DP, Milla M, Montgomery GW, Morley KI, Mowat C, Ng A, Newman W, Ophoff RA, Papi L, Palmieri O, Peyrin-Biroulet L, Panes J, Phillips A, Prescott NJ, Proctor DD, Roberts R, Russell R, Rutgeerts P, Sanderson J, Sans M, Schumm P, Seibold F, Sharma Y, Simms LA, Seielstad M, Steinhart AH, Targan SR, van den Berg LH, Vatn M, Verspaget H, Walters T, Wijmenga C, Wilson DC, Westra HJ, Xavier RJ, Zhao ZZ, Ponsioen CY, Andersen V, Torkvist L, Gazouli M, Anagnou NP, Karlsen TH, Kupcinskas L, Sventoraityte J, Mansfield JC, Kugathasan S, Silverberg MS, Halfvarson J, Rotter JI, Mathew CG, Griffiths AM, Gearry R, Ahmad T, Brant SR, Chamaillard M, Satsangi J, Cho JH, Schreiber S, Daly MJ, Barrett JC, Parkes M, Annese V, Hakonarson H, Radford-Smith G, Duerr RH, Vermeire S, Weersma RK, Rioux JD. Metaanalysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nature Genetics 2011;43: 246-252.</gtr:impact><gtr:outcomeId>11C940B1FC1-1</gtr:outcomeId><gtr:partnerContribution>Data analysis, performance of IBD GWAS, meta-analyses of IBD GWAS, intellectual input</gtr:partnerContribution><gtr:piContribution>Data sharing, intellectual input</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:description>IBD BIOM</gtr:description><gtr:id>D1033FED-B75A-4E7B-A18A-9681C26D7787</gtr:id><gtr:impact>Considerable progress has been made in the IBD BIOM Research Programme and new data have been generated, and we anticipate publications over the next 12 months. 
This is the first publication of the IBD BIOM Group:
PMID 24912389.</gtr:impact><gtr:outcomeId>HwYurWhebmi-1</gtr:outcomeId><gtr:partnerContribution>Recruitment and scientific programme.</gtr:partnerContribution><gtr:piContribution>Co-ordinator, lead applicant, recruitment centre and epigenetic discovery programme.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>?rebro University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>IBD CHARACTER</gtr:description><gtr:id>786C9BAB-E359-40AD-8AED-C05B054F2D59</gtr:id><gtr:impact>Biobank established. Data are being generated and publications are anticipated over the next 12 months.</gtr:impact><gtr:outcomeId>aJhmGMubqV2-1</gtr:outcomeId><gtr:partnerContribution>Recruitment and scientific activities.</gtr:partnerContribution><gtr:piContribution>Co-ordinator, recruitment and scientific activities.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Chemistry Manchester</gtr:department><gtr:description>Metabolomics colloboration</gtr:description><gtr:id>87982A36-B7FD-458F-84C7-61D0227AFC84</gtr:id><gtr:impact>None to date</gtr:impact><gtr:outcomeId>AhsJPRNpdxP-1</gtr:outcomeId><gtr:partnerContribution>Prof Goodacre's lab in Manchester will provide their expertise and the use of their equipment. They will also train Dr Kennedy (Edinburgh) and Dr Hildebrand (Inverness) in the analysis of the metabolomics data.</gtr:partnerContribution><gtr:piContribution>We have collected samples, in collaboration with partners in Inverness, for metabolomics analysis to better understand the metabolomic profile of inflammatory bowel disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Investigation of mitochondria DNA as biomarker in IBD</gtr:description><gtr:id>D9B8FA2F-C267-4470-985B-A92022447224</gtr:id><gtr:impact>Multidisciplinary basic and clinical research approach to a novel triggering factor in IBD. Potential for new therapy.</gtr:impact><gtr:outcomeId>550c0f17607b83.95833820-1</gtr:outcomeId><gtr:partnerContribution>Technical scientific expertise/</gtr:partnerContribution><gtr:piContribution>Linking human IBD cohort with functional studies of gut mitochondria DNA in inflammation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Raigmore Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Colorectal Surgery</gtr:department><gtr:description>Metabolomics colloboration</gtr:description><gtr:id>C38E4077-EB31-4FA8-A519-665F0CD68E06</gtr:id><gtr:impact>None to date</gtr:impact><gtr:outcomeId>AhsJPRNpdxP-2</gtr:outcomeId><gtr:partnerContribution>Prof Goodacre's lab in Manchester will provide their expertise and the use of their equipment. They will also train Dr Kennedy (Edinburgh) and Dr Hildebrand (Inverness) in the analysis of the metabolomics data.</gtr:partnerContribution><gtr:piContribution>We have collected samples, in collaboration with partners in Inverness, for metabolomics analysis to better understand the metabolomic profile of inflammatory bowel disease.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Pharmacogenetics Unit Liverpool</gtr:department><gtr:description>ABCB5 function in corticosteroid response in inflammatory bowel disease</gtr:description><gtr:id>46B1EAC6-8833-4DE1-9CFD-D86B91ED44BC</gtr:id><gtr:impact>ABCB5-MEDIATED TRANSPORT OF CORTICOSTEROIDS: A ROLE FOR ABCB5 IN INFLAMMATORY BOWEL DISEASE
Oral abstract presented at the United European Gastroenterology Week 2011. Manuscript preparation in progress.</gtr:impact><gtr:outcomeId>jHmT8cEJN4j-1</gtr:outcomeId><gtr:partnerContribution>Co-application of a successful project grant from National Association of Crohn's and Colitis to study the functional effect of ABCB5 on steroid response - further expanding our unit's expertise in translating genetic to functional work.</gtr:partnerContribution><gtr:piContribution>We made the discovery of 4 genes that predicted the outcomes of corticosteroid response using our patient cohort and have collaborated with the national pharmacogenetics unit to further investigate the functional consequence of the top ranking gene, ABCB5 gene. This work is still in progress but has so far revealed new insight that this gene participates in basolateral transport of corticosteroids in the intestinal epithelium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>British Society of Gastroenterology Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E8E1E3E4-6E6C-40AE-8304-A9C9F449CEB9</gtr:id><gtr:impact>Nil</gtr:impact><gtr:outcomeId>kbQugfnEJ9S</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University of Edinburgh Centre for Inflammation Research Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FC75B490-453D-432B-B1C6-4C00F0438468</gtr:id><gtr:impact>University of Edinburgh Internal Lecture. Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b206a386f5.54564972</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Guest Speaker University of Cork</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9E23F462-67CC-4D00-BB51-19FD238A2B39</gtr:id><gtr:impact>Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2c1f52d0ed8.66990843</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Society of Gastroenterology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>93692271-87BC-493C-B34C-109DE2361D7D</gtr:id><gtr:impact>Discussion was stimulated.

Further research projects proposed.</gtr:impact><gtr:outcomeId>5460ee45a683a4.32230764</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CICRA IBD FAMILY INFORMATION DAY</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1F749A17-11BA-4B81-817B-E0A732E702A5</gtr:id><gtr:impact>Information given to families.

Increase in patient interest in research.</gtr:impact><gtr:outcomeId>551423a6ef8dc5.57728723</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Falk IBD Meeting Birmingham</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>82F7632B-E5F4-486E-9D3F-233DCBE1E6A4</gtr:id><gtr:impact>Dr Falk Meeting 2016 - Disseminaton of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b9dc49adc4.14929342</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to private charity - Cure Crohn's and Colitis organisation.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9D97744C-70CF-473A-96C8-DC5EBEE55555</gtr:id><gtr:impact>Presentation to the Cure Crohn's and Colitis (C3) charity board members of current potential translational aspects of genetic work - including pharmacogenetics of corticosteroid response.


This has led to further involvement of C3 in co-funding further work in Edinburgh GI Unit - currently in the development of a national biobank of inflammatory bowel disease in Scotland. Funding of CSO was acknowledged.</gtr:impact><gtr:outcomeId>E9274eLHhYf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Digestive Disease Week San Diego, California, USA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>37F0D916-2E55-4DF1-8658-07A32EA8913D</gtr:id><gtr:impact>Presentation given at Digestive Disease Week, American Gastroenterology Association. Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b3077feac7.41568044</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UNIVERSITY OF EDINBURGH, PUBLIC LECTURE, QUEENS MEDICAL RESEARCH INSTITUTE</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FF8DE2D1-FEB3-4328-89C8-6F67153EE51C</gtr:id><gtr:impact>Dissemination of scientific knowledge and advances in patient care, to general public, clinicians, scientists.</gtr:impact><gtr:outcomeId>58c2c14c0420b7.14176393</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open Symposium EU Project Forum, Amsterdam, Netherlands</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3A88C355-3256-46B1-8F7C-273E043F4BC8</gtr:id><gtr:impact>Collaborative Meeting for EU Collaborators during ECCO Amsterdam meeting. Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b05496dda4.84416639</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford Masterclass 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>78A0E7BF-24CA-4AB7-82EC-ECFDD312532B</gtr:id><gtr:impact>Giving talk at Oxford Masterclass Meeting - dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b8b5d16869.16779304</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release of ABCB5 transport as a mechanism of steroid resistance in inflammatory bowel disease.</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AB4E3363-38A4-41CA-AA83-713F134D6F00</gtr:id><gtr:impact>Following successful funding by National Association of Crohn's and Colitis (NACC) to further study the functional aspects of ABCB5 gene identified by the CSO-funded study, a press release was given - acknowledging the work which led to the discovery of these genes.

The press release achieved wide national dissemination and led to many inquiries from patient groups within/out of the field of inflammatory bowel disease.</gtr:impact><gtr:outcomeId>QNcxqYck9D7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NACC LECTURES</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>99957ECC-F5E6-4801-96D2-89AC73D2FCFF</gtr:id><gtr:impact>HEIGHTENED INTEREST AND AWARENESS OF ON-GOING RESEARCH WORK IN CROHN'S DISEASE

MEDIA INTEREST FOLLOWED.</gtr:impact><gtr:outcomeId>eY9pWtNSgRE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to a charity C3</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D2AF592C-57F7-4E8B-A158-EBC6584B162A</gtr:id><gtr:impact>Board meeting attended by approx 10 people. Dr Kennedy presented his research to date which provoked interested discussion.

Expression of interest for possible further funding.</gtr:impact><gtr:outcomeId>JDLQETkcaVN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Society of Gastroenterology Meeting in Liverpool</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A99364B4-3CF0-4FE7-9F86-EA452E4028DA</gtr:id><gtr:impact>Giving a talk at the annual British Society of Gastroenterology Meeting. Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b809dd2da3.10820942</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Swedish Gastrodagarna</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>413BB23F-28D8-46E2-BA84-A5F12B69C926</gtr:id><gtr:impact>Lecture given to conference in Orebo, Sweden, on 30 May 2013.

Nil</gtr:impact><gtr:outcomeId>d1G1Vh2G22Q</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to UEGW on Thiopurine Withdrawal</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EC47DD25-9347-4DB9-AA16-F35BC72DB3A6</gtr:id><gtr:impact>UEGW, Stockholm 2011. Well-attended oral presentation.

Kennedy NA, Gambles CJ, Musy RM, Jones GR, Arnott ID, Satsangi J, Lees CW. Predictive Factors of Disease Relapse Following Thiopurine Withdrawal for Sustained Clinical Remission of IBD.

We have subsequently presented this data at a British meeting and have extended the study to include other British sites. A paper is in progress.</gtr:impact><gtr:outcomeId>KvkfiXhC8Wh</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>DDW presentation on Mercaptopurine following Azathioprine</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E8471983-B8E1-4F8A-8282-7A0E4D3ED363</gtr:id><gtr:impact>Well-attended oral presentation at DDW May 2012, San Diego (www.ddw.org).
Rhatigan EB, Kennedy NA, Arnott ID, Noble CL, Shand AG, Satsangi J, Lees CW. A Trial With Mercaptopurine Following Azathioprine Intolerance is a Safe Treatment Strategy for the Majority of Patients With IBD. DDW 2012. (Presentation prepared and given by Dr Kennedy.) Gastroenterology 2012;142:S-206.



Paper underway and will be submitted soon.</gtr:impact><gtr:outcomeId>QAe4yRwHhSz</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EU IBD-BIOM Meeting in Dubrovnik Croatia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8E220D8F-7182-4645-8659-74EE2246EA3C</gtr:id><gtr:impact>Annual EU BIOM Meeting with collaborators in Europe and elsewhere. Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b1044e9480.27099107</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>20th Advanced Gastroenterology &amp; Hepatology Course, Royal College of Physicians of Edinburgh</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>58E6AA76-F91D-45C7-AFB7-40D635945AEF</gtr:id><gtr:impact>Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2ad5a3bdc73.06353875</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to CCUK Charity April 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>47C972DB-5646-43E3-8F38-94BB93491841</gtr:id><gtr:impact>200 delegates. Very positive feedback.

Nil</gtr:impact><gtr:outcomeId>ATqpN8vRtZR</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EU IBD Character Meeting Barcelona Spain</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B5D85EE1-0476-45C9-AD33-196CF2BBE1D0</gtr:id><gtr:impact>Annual Meeting with collaborators throughout Europe and elsewhere. Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b96d4fd839.82211780</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Falk Foundation Gastroenterology Study Day, Birmigham</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>409F1DC5-42DA-4A32-BA7B-3841D215B5CB</gtr:id><gtr:impact>Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2af2f2be568.25528120</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>257684</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CSO PROJECT GRANT SUPPORT - EXPERIMENTAL &amp;amp; TRANSLATIONAL MEDCINE BOARD</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:fundingRef>ETM/137</gtr:fundingRef><gtr:id>2AA0010B-EFCB-46F5-9DBA-6E96E4F0656E</gtr:id><gtr:outcomeId>rbusLBvpbs50</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>FP7 EC IBD CHARACTER</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>305676-2</gtr:fundingRef><gtr:id>C61DBE67-51C3-4805-A820-9D787806301C</gtr:id><gtr:outcomeId>d2UXTjnoB6x</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2738767</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC CLINICAL TRIALS GRANT</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0600329</gtr:fundingRef><gtr:id>81076DD9-F737-4CB3-8DC3-96CFF0F1532A</gtr:id><gtr:outcomeId>ZL7BzUJE6Ex0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5975589</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Horizon 2020 - Research and Innovation Framework Programme</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>PHC-13-2014</gtr:fundingRef><gtr:id>D4922D84-67B7-4EF8-95F4-558338F03D4C</gtr:id><gtr:outcomeId>5515362aac4e30.83818928</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>National Association of Crohn's and Colitis Project Grant</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>National Association for Colitis and Crohn?s Disease (NACC)</gtr:fundingOrg><gtr:id>4734772D-7106-4453-A913-D58FD65DF021</gtr:id><gtr:outcomeId>ZdVwCZRKydU0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5975589</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>New Therapies for chronic non-communicable diseases - BIOCYLE</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>7C69F1DC-89DC-4BEE-99CE-1B5881289CC1</gtr:id><gtr:outcomeId>56d70e64f41235.09555492</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>647570</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR BioResource</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M00533X/1 Parkes</gtr:fundingRef><gtr:id>A930F706-9ED8-4C50-852C-82AEEA0406E7</gtr:id><gtr:outcomeId>55153520148af3.28366646</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>FP 7 EC IBD BIOM GRANT</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>305479-2</gtr:fundingRef><gtr:id>0AB3D23F-8757-4648-A46D-390F13000D08</gtr:id><gtr:outcomeId>h6FyB2kHV2r</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>224998</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Grant Application</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:fundingRef>ETM/395</gtr:fundingRef><gtr:id>4EDBAE4B-8910-4FEF-9A53-8DD45115BA69</gtr:id><gtr:outcomeId>55153860d32a47.50379632</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>251648</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Clinical Research Training Fellowship</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>09743/Z/11/Z</gtr:fundingRef><gtr:id>BCED00B8-B1C1-47D2-8E30-43C5C2CA9565</gtr:id><gtr:outcomeId>N1hvWiYohWb</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Edinburgh GI Trustees</gtr:description><gtr:fundingOrg>University of Edinburgh</gtr:fundingOrg><gtr:id>43D9DD9B-8A84-493B-AE87-F2B1D99B639B</gtr:id><gtr:outcomeId>550c0e098c54c7.85763277</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>99638</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MicroRNA profiling in Inflammatory Bowel Diseases: The application of Next Generation Sequencing</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>Crohn's and Colitis UK</gtr:fundingOrg><gtr:id>ED49BEC6-6E45-4036-B5BF-B42ED869577F</gtr:id><gtr:outcomeId>58c298d32fef73.81206161</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BRITISH SOCIETY OF GASTROENTEROLOGY IBD GUIDELINES</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0ABF8FC9-0F69-4304-BD35-0E1909CBEE0D</gtr:id><gtr:outcomeId>kjQBYrVoUSn</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have compiled the largest database of corticosteroid response in newly diagnosed patients with IBD across a 13-year period in Lothian.</gtr:description><gtr:id>63F3BFB1-DE62-4856-AEE7-1997F12C89CB</gtr:id><gtr:impact>Further clinical studies to longitudinally study the clinical outcomes of this cohort have been performed and results presented in national and international meetings.</gtr:impact><gtr:outcomeId>RAoGJdwBZba</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Database of 13-year inception cohort of corticosteroid outcome in IBD.</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Phenotyping of paediatric IBD with relation to response outcomes to corticosteroids. The objective is to study pharmacogenetic contribution of ABCB5 gene to this clinical end-point.</gtr:description><gtr:id>B277739B-DDF2-490F-A79F-526A07745C59</gtr:id><gtr:impact>Still in progress.</gtr:impact><gtr:outcomeId>axDiPngEyEM</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Paediatric IBD Scottish Cohort</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0B54E989-96B5-4B70-92FA-ED30C7A35B87</gtr:id><gtr:title>Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3973f4184be66ec3d0d2394aae288cc3"><gtr:id>3973f4184be66ec3d0d2394aae288cc3</gtr:id><gtr:otherNames>Cleynen I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>56d59146d4a188.30542648</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68AAF872-8165-43C3-9943-C3A912DBCB41</gtr:id><gtr:title>Erratum: A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bd098697bd70f44f21e158259d0b6f4"><gtr:id>1bd098697bd70f44f21e158259d0b6f4</gtr:id><gtr:otherNames>Rivas MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a8e92efe6ad26.34012146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>069B58F7-AF0A-4849-9BC7-2B3628ACC4FE</gtr:id><gtr:title>Genetic sharing and heritability of paediatric age of onset autoimmune diseases.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1605ad728ecb6d5cabf79b7add99fc60"><gtr:id>1605ad728ecb6d5cabf79b7add99fc60</gtr:id><gtr:otherNames>Li YR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56d5917cb72e78.72259304</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14D6EE5D-F700-474B-A57A-1D86AB7B07D9</gtr:id><gtr:title>Genetics of childhood-onset inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>iLs6pZmcL7k</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBC84FBA-7A18-4A18-8622-F955039EF4E6</gtr:id><gtr:title>A plea for TDM-based optimisation for treatment of Crohn's disease - Authors' reply.</gtr:title><gtr:parentPublicationTitle>The lancet. Gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a8e9126a6a110.34045519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3348218E-BB12-437B-9E12-6FDFB982B510</gtr:id><gtr:title>The changing epidemiology of paediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>XTSsJNDsyCu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DC43B3C-0587-4C52-A38F-44DF455E2004</gtr:id><gtr:title>The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>pm_15892_22_22370604</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51B5DA49-0524-4909-90E1-973BF67AB5CB</gtr:id><gtr:title>Growth in children receiving contemporary disease specific therapy for Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff310746e9ace20777a8783a2e3393dd"><gtr:id>ff310746e9ace20777a8783a2e3393dd</gtr:id><gtr:otherNames>Malik S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>pm_16612_22_22685044</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D308DFC9-1B1B-4B99-95E5-A28B3DA39B6C</gtr:id><gtr:title>Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a31994e93582d0033292b37419bb3c5"><gtr:id>5a31994e93582d0033292b37419bb3c5</gtr:id><gtr:otherNames>Hawkey CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>56d591072b9aa5.82876438</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EDECFED-2AA7-461F-8A6E-3CE7193EF83B</gtr:id><gtr:title>Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be7f3c9c818fb8f7c8a3e8507c421eed"><gtr:id>be7f3c9c818fb8f7c8a3e8507c421eed</gtr:id><gtr:otherNames>Ventham NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>pm_15892_22_23751777</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5198A19F-8E2A-46C5-A2C5-2BA923854493</gtr:id><gtr:title>Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f5948b5a7f162e349b3184da5420ba0"><gtr:id>5f5948b5a7f162e349b3184da5420ba0</gtr:id><gtr:otherNames>Wang K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>54648bb9c704b0.35731607</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C63C9A1A-DE2B-4E51-BB4B-74B5A87565B0</gtr:id><gtr:title>Novel loci associated with increased risk of sudden cardiac death in the context of coronary artery disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9990519301f803df7f03605aaaeeab3"><gtr:id>b9990519301f803df7f03605aaaeeab3</gtr:id><gtr:otherNames>Huertas-Vazquez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15892_22_23593153</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53EB8D9E-18C2-4179-8C55-E0F6BD7E8D74</gtr:id><gtr:title>Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61679ec8c97393a31d71ea64b48eb8c7"><gtr:id>61679ec8c97393a31d71ea64b48eb8c7</gtr:id><gtr:otherNames>Torres J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>56d591b51958b1.93000793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D6E0C2B-A9D5-4862-B61F-1D32A8D4C5AA</gtr:id><gtr:title>Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1605ad728ecb6d5cabf79b7add99fc60"><gtr:id>1605ad728ecb6d5cabf79b7add99fc60</gtr:id><gtr:otherNames>Li YR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>56d591e6bb3c07.67674905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4ED7CEBE-74FE-4938-A1CE-8E8293381C0A</gtr:id><gtr:title>Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a255a9d973fc3e59f2dbd0ef03280b76"><gtr:id>a255a9d973fc3e59f2dbd0ef03280b76</gtr:id><gtr:otherNames>Franke A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>J7DHfkYqBCx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F0C6271-AA62-40BE-AC74-9AACF3888F78</gtr:id><gtr:title>Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50e6243a98509e54910c6932cb74b8db"><gtr:id>50e6243a98509e54910c6932cb74b8db</gtr:id><gtr:otherNames>Lee JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5a8e918e77fa38.23245314</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAE66A7B-80F3-4817-B392-C20BF3B373DC</gtr:id><gtr:title>Pathogenesis of Crohn's disease.</gtr:title><gtr:parentPublicationTitle>F1000prime reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d303a6716833659b362d79806b3d7355"><gtr:id>d303a6716833659b362d79806b3d7355</gtr:id><gtr:otherNames>Boyapati R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2051-7599</gtr:issn><gtr:outcomeId>56d5925b5ccb62.11605424</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3D2DCD2-082D-4645-8AB1-A2395115C26F</gtr:id><gtr:title>The intermediate filament protein, vimentin, is a regulator of NOD2 activity.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e44fcfb9fb3237b0ce7a55d7295b2a46"><gtr:id>e44fcfb9fb3237b0ce7a55d7295b2a46</gtr:id><gtr:otherNames>Stevens C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>pm_15892_22_22684479</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35F0771D-3B2E-4587-B83A-2B242EA11745</gtr:id><gtr:title>Paneth cell marker CD24 in NOD2 knockout organoids and in inflammatory bowel disease (IBD).</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f444492accbb6a473246d6fe44c8a127"><gtr:id>f444492accbb6a473246d6fe44c8a127</gtr:id><gtr:otherNames>Van Limbergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>pm_15892_22_23704317</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>446DF64D-073C-4871-9054-AD8663539A06</gtr:id><gtr:title>Guidelines for the management of inflammatory bowel disease in adults.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5872a5fbb017c81d000ff8540547d87a"><gtr:id>5872a5fbb017c81d000ff8540547d87a</gtr:id><gtr:otherNames>Mowat C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>KtfRw17SVWN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41EA5BD3-275C-4A67-8BFF-4FEE9755769D</gtr:id><gtr:title>Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control study.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c1396e262f01d61d4d04461debba360"><gtr:id>3c1396e262f01d61d4d04461debba360</gtr:id><gtr:otherNames>Andersen V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>Rurfy2dphrC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5631C88F-200F-440D-9006-88D0AF5F37BE</gtr:id><gtr:title>Genes in inflammatory bowel disease: lessons from complex diseases.</gtr:title><gtr:parentPublicationTitle>Clinical medicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1470-2118</gtr:issn><gtr:outcomeId>pm_16612_22_21404774</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32FCB7E7-6477-49C7-9344-806FC7C40159</gtr:id><gtr:title>Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>56d5905670cfd4.36847884</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F187AB1D-DD1C-447B-BAC2-4E3F4687B49C</gtr:id><gtr:title>Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7df3307e11c9bb132b88045342e68068"><gtr:id>7df3307e11c9bb132b88045342e68068</gtr:id><gtr:otherNames>Ruark E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15892_22_23242139</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09FF778D-CDFB-4074-B428-A1F2280C69E7</gtr:id><gtr:title>Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08112693a12b70debb270f3297d29147"><gtr:id>08112693a12b70debb270f3297d29147</gtr:id><gtr:otherNames>Fisher SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>RoPRWkR91YN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9171C1E8-48BB-44F0-9E0B-FACC0B276BB1</gtr:id><gtr:title>A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>pm_15892_22_24117596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AB5E2EE-F27E-4312-9C63-C41C5E87040C</gtr:id><gtr:title>Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases.</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7cfe472cce65a6e4c1409d62261cbc1"><gtr:id>a7cfe472cce65a6e4c1409d62261cbc1</gtr:id><gtr:otherNames>Kalla R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>58b95f2c467ad5.19736272</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65B6B503-332B-47EE-B884-E1B04A985A34</gtr:id><gtr:title>Fine-mapping inflammatory bowel disease loci to single-variant resolution.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e94754791b4be0de589dc01808c98d92"><gtr:id>e94754791b4be0de589dc01808c98d92</gtr:id><gtr:otherNames>Huang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5a8e9092769757.26209491</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF049C95-0F1C-415D-9769-F1EFF24247F8</gtr:id><gtr:title>A role for vimentin in Crohn disease.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>pm_15892_22_22929019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8230B6BF-79EC-4519-9C2C-4F05FCA61F6A</gtr:id><gtr:title>Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee2f00367823c286d1309d18b6f74ea2"><gtr:id>ee2f00367823c286d1309d18b6f74ea2</gtr:id><gtr:otherNames>Trbojevic Akmacic I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>56d59285c8e304.79794692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C9DDFD6-79C7-4BAD-84CD-8A4617D81271</gtr:id><gtr:title>Exploring the hidden heritability of inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5da24c4aa9fd3d3f04a822291d0cbde0"><gtr:id>5da24c4aa9fd3d3f04a822291d0cbde0</gtr:id><gtr:otherNames>Satsangi J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>545a46f1843962.24061166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF7728B0-F70A-4B91-AB7C-386B5CFE0DF5</gtr:id><gtr:title>Tuberous sclerosis-2 (TSC2) regulates the stability of death-associated protein kinase-1 (DAPK) through a lysosome-dependent degradation pathway.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df1446d37ddbc9ae923008079c6a1ce3"><gtr:id>df1446d37ddbc9ae923008079c6a1ce3</gtr:id><gtr:otherNames>Lin Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>jtodYsfKA5a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4FCB1AA-B05F-47BF-AFEE-64BF0CC7D790</gtr:id><gtr:title>Measurement methods and accuracy in copy number variation: failure to replicate associations of beta-defensin copy number with Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f464f9e14d797f32cb291cb1c8e1802b"><gtr:id>f464f9e14d797f32cb291cb1c8e1802b</gtr:id><gtr:otherNames>Aldhous MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>eCiPTvpufSX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC0BCBA6-8E46-4B9F-B9D4-AF9C303A04E9</gtr:id><gtr:title>Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>The lancet. Gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5872a5fbb017c81d000ff8540547d87a"><gtr:id>5872a5fbb017c81d000ff8540547d87a</gtr:id><gtr:otherNames>Mowat C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5a8e90f207add3.89399707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51DC93A1-1F2F-4990-A969-E26CFDE683C0</gtr:id><gtr:title>A Method to Exploit the Structure of Genetic Ancestry Space to Enhance Case-Control Studies.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/115678a5f93d1df09c752d1cca5b1c48"><gtr:id>115678a5f93d1df09c752d1cca5b1c48</gtr:id><gtr:otherNames>Bodea CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>58b95f2d9537c6.45708707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9C272CF-3A8A-4FA0-8231-5FBAAD5E81E9</gtr:id><gtr:title>New IBD genetics: common pathways with other diseases.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd368253fec639b465fd164d29cb2ba"><gtr:id>2bd368253fec639b465fd164d29cb2ba</gtr:id><gtr:otherNames>Lees CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>daGJcP4s521</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70F7A027-326F-497B-9FCA-DAAE0E24C4CE</gtr:id><gtr:title>Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a32e5e38a8b83514d902fbe4626b80ee"><gtr:id>a32e5e38a8b83514d902fbe4626b80ee</gtr:id><gtr:otherNames>Wellcome Trust Case Control Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>UyQWDXLRk4W</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04689090-0756-4898-AFBD-81423636A02B</gtr:id><gtr:title>Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e051e9782b413d28b51dac97e8d57905"><gtr:id>e051e9782b413d28b51dac97e8d57905</gtr:id><gtr:otherNames>Rossin EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>q5MYtgvmNDd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8791E968-0E6D-4164-A72B-9D79E30C5828</gtr:id><gtr:title>Resolution of non-small-cell lung cancer after withdrawal of anti-TNF therapy.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd368253fec639b465fd164d29cb2ba"><gtr:id>2bd368253fec639b465fd164d29cb2ba</gtr:id><gtr:otherNames>Lees CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>NUUVMrJXDjf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA8D78B0-4AAC-4C02-9DBA-E6AA7BFA06A4</gtr:id><gtr:title>Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b004e39d62a9fcb4cc88a22083af34fa"><gtr:id>b004e39d62a9fcb4cc88a22083af34fa</gtr:id><gtr:otherNames>International Multiple Sclerosis Genetics Consortium (IMSGC)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56e17613414cd8.36193009</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>051512F7-B0F7-4A9C-B7F8-CF7DC129AEF1</gtr:id><gtr:title>Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50e6243a98509e54910c6932cb74b8db"><gtr:id>50e6243a98509e54910c6932cb74b8db</gtr:id><gtr:otherNames>Lee JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>pm_15892_22_24035192</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A27090C-A57F-44EC-B3B3-260757D86D64</gtr:id><gtr:title>The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd368253fec639b465fd164d29cb2ba"><gtr:id>2bd368253fec639b465fd164d29cb2ba</gtr:id><gtr:otherNames>Lees CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>Q89Qmm4RUEy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF2F809A-B113-4549-8541-3CBE0E3400A6</gtr:id><gtr:title>Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a94bd817e0697ab1ede1ac552afec188"><gtr:id>a94bd817e0697ab1ede1ac552afec188</gtr:id><gtr:otherNames>Wain LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn><gtr:outcomeId>58b95f2ec62925.28949032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8AA25C0-444E-4C73-B5A2-4E4E65450F3E</gtr:id><gtr:title>How to Apply for and Secure EU Funding for Collaborative IBD Research Projects.</gtr:title><gtr:parentPublicationTitle>Journal of Crohn's &amp; colitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5da24c4aa9fd3d3f04a822291d0cbde0"><gtr:id>5da24c4aa9fd3d3f04a822291d0cbde0</gtr:id><gtr:otherNames>Satsangi J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-9946</gtr:issn><gtr:outcomeId>56d590d59db902.37993287</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A04E601-0FF0-4897-B5A3-E870A959DC86</gtr:id><gtr:title>PepT1 oligopeptide transporter (SLC15A1) gene polymorphism in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd29fe15ac25ec5c0474193a1330a56f"><gtr:id>bd29fe15ac25ec5c0474193a1330a56f</gtr:id><gtr:otherNames>Zucchelli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>MacSUQoiaE8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C4E73E6-FD80-4FB5-B97A-A007A00B264A</gtr:id><gtr:title>Efficacy and complications of adalimumab treatment for medically-refractory Crohn's disease: analysis of nationwide experience in Scotland (2004-2008).</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64f42b266fd11aa87e2c88a384ee9d26"><gtr:id>64f42b266fd11aa87e2c88a384ee9d26</gtr:id><gtr:otherNames>Ho GT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>54648bdd6cea12.43657137</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F67F96C-A895-4744-8400-B63BF4BF6F80</gtr:id><gtr:title>Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8e45c11ff8b196523502e41d8ce46cf"><gtr:id>c8e45c11ff8b196523502e41d8ce46cf</gtr:id><gtr:otherNames>Anderson CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>FSDmJt2LES7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F815B035-04DE-459C-8531-682F06195A30</gtr:id><gtr:title>Analysis of germline GLI1 variation implicates hedgehog signalling in the regulation of intestinal inflammatory pathways.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd368253fec639b465fd164d29cb2ba"><gtr:id>2bd368253fec639b465fd164d29cb2ba</gtr:id><gtr:otherNames>Lees CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>WQRtXHaygi2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B047906-BAAD-4C90-929F-58DE18599210</gtr:id><gtr:title>Systematic meta-analyses and field synopsis of genetic and epigenetic studies in paediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93f8556619f3487d06c35513ec7d86fb"><gtr:id>93f8556619f3487d06c35513ec7d86fb</gtr:id><gtr:otherNames>Li X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58b95f2bb9b2e7.44500489</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B393B084-D501-446A-BC9F-B655E8D6427D</gtr:id><gtr:title>Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/546b1e0b1339f37380d709047c712095"><gtr:id>546b1e0b1339f37380d709047c712095</gtr:id><gtr:otherNames>Barrett JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>D4cb4VWDpaN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>404CB7FA-7253-4C8C-871B-D8CB1D6375A9</gtr:id><gtr:title>Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f5948b5a7f162e349b3184da5420ba0"><gtr:id>5f5948b5a7f162e349b3184da5420ba0</gtr:id><gtr:otherNames>Wang K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>VYKxNnLQqCX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E120F2FB-27D5-4FCB-879D-88FABC7ABEC8</gtr:id><gtr:title>Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8ba377304d5e7fd1f2b7d997300293a"><gtr:id>c8ba377304d5e7fd1f2b7d997300293a</gtr:id><gtr:otherNames>Nimmo ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>545a461c3108d9.10816226</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B069B749-1752-46DA-B78F-94612ECC4E5C</gtr:id><gtr:title>Psychosocial functioning and health-related quality of life in paediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Journal of pediatric gastroenterology and nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/886606afd4f9c4c3637aefb0a28e1750"><gtr:id>886606afd4f9c4c3637aefb0a28e1750</gtr:id><gtr:otherNames>Ross SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0277-2116</gtr:issn><gtr:outcomeId>pm_16612_22_21822149</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79689C09-E4DE-4413-88E8-5D0E0201785B</gtr:id><gtr:title>Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ba4484ccc898295a012002024ec60c3"><gtr:id>8ba4484ccc898295a012002024ec60c3</gtr:id><gtr:otherNames>de Lange KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58b95f2b3746f1.38171809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B754D7C-B281-44AF-92D7-71C9F61A6CCD</gtr:id><gtr:title>Lack of association between cervical dysplasia and IBD: a large case-control study.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd368253fec639b465fd164d29cb2ba"><gtr:id>2bd368253fec639b465fd164d29cb2ba</gtr:id><gtr:otherNames>Lees CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>VtsVJkzf7qn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0B60DCA-B729-478A-85B0-A06241E14B03</gtr:id><gtr:title>Multiple sclerosis in the context of TNF blockade and inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33800cbdd8ec2b7e624dd14dad808264"><gtr:id>33800cbdd8ec2b7e624dd14dad808264</gtr:id><gtr:otherNames>Hare NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>pm_15892_22_22240391</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3162E85-A524-4B6B-80E1-76DB1741526C</gtr:id><gtr:title>Magnetic resonance follow-through imaging for evaluation of disease activity in ileal Crohn's disease: an observational, retrospective cohort study.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bffe2c88e0743de298720c2901b77790"><gtr:id>bffe2c88e0743de298720c2901b77790</gtr:id><gtr:otherNames>Parisinos CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>Z5yfgFf3n1f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64708C19-BAE2-4A50-A856-EE867E5E31B7</gtr:id><gtr:title>Editorial: the influence of genetic factors in mediating the effects of tobacco smoke in IBD.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40332de4193aa1266d1b40d478d98ba7"><gtr:id>40332de4193aa1266d1b40d478d98ba7</gtr:id><gtr:otherNames>Adams A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>5a8e8f5a230d03.85643658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF9A5790-1E87-4C19-A221-0DF648A9B77F</gtr:id><gtr:title>Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>pm_15892_22_22221081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05DE3626-9350-49F1-A9DD-576AFF8A40AC</gtr:id><gtr:title>Crohn's disease.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7cfe472cce65a6e4c1409d62261cbc1"><gtr:id>a7cfe472cce65a6e4c1409d62261cbc1</gtr:id><gtr:otherNames>Kalla R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>551048e730be34.81064895</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A296947-D98F-4BFB-8411-6696865845E9</gtr:id><gtr:title>Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c5db92b3cd994f383d1bd62191511d"><gtr:id>90c5db92b3cd994f383d1bd62191511d</gtr:id><gtr:otherNames>Cross-Disorder Group of the Psychiatric Genomics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58b987834b59e0.03036160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4982CAD-9CC5-46DA-B8C1-D55799EDB23D</gtr:id><gtr:title>Seven newly identified loci for autoimmune thyroid disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/944c80fb10c6590f6168fa3c3cf2c8c1"><gtr:id>944c80fb10c6590f6168fa3c3cf2c8c1</gtr:id><gtr:otherNames>Cooper JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_15892_22_22922229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF13CCE5-A579-484E-801C-3CFDCB0E14EB</gtr:id><gtr:title>Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67c4802bef8cffec7e1326194d07eaa1"><gtr:id>67c4802bef8cffec7e1326194d07eaa1</gtr:id><gtr:otherNames>Jostins L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15892_22_23128233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C778D802-B184-45D3-8F18-CDDC07188CF4</gtr:id><gtr:title>MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64f42b266fd11aa87e2c88a384ee9d26"><gtr:id>64f42b266fd11aa87e2c88a384ee9d26</gtr:id><gtr:otherNames>Ho GT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>5a3068d0a40373.77821407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4C70BF0-7065-44DD-91F4-CC6B1E33C858</gtr:id><gtr:title>Characterisation of osteoprotegerin autoantibodies in coeliac disease.</gtr:title><gtr:parentPublicationTitle>Calcified tissue international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8924067a61debc954d4516114f2908a2"><gtr:id>8924067a61debc954d4516114f2908a2</gtr:id><gtr:otherNames>Real A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0171-967X</gtr:issn><gtr:outcomeId>58b95f2f11e9b3.25352146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BCBE730-2D48-4EF5-9FC1-825AA4C3AAE3</gtr:id><gtr:title>Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f08243406518279380370a3fd236f37"><gtr:id>4f08243406518279380370a3fd236f37</gtr:id><gtr:otherNames>Liu JZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56d5922a2ea727.13635506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E31A0AF8-748C-4E7F-BE11-1F782112CFF8</gtr:id><gtr:title>Fecal calprotectin predicts the clinical course of acute severe ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64f42b266fd11aa87e2c88a384ee9d26"><gtr:id>64f42b266fd11aa87e2c88a384ee9d26</gtr:id><gtr:otherNames>Ho GT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>54648b953c9942.46219440</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3075D25-6DF0-4770-98A6-A986401DDC0D</gtr:id><gtr:title>Detailed haplotype-tagging study of germline variation of MUC19 in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c03c031f93314568064c52c650a9dae9"><gtr:id>c03c031f93314568064c52c650a9dae9</gtr:id><gtr:otherNames>Phillips AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>pKTBbsdGKGu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BA8B640-6AFB-46B2-92F3-51BF88E2945C</gtr:id><gtr:title>Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eceaa0d8d49922665570d609c2586922"><gtr:id>eceaa0d8d49922665570d609c2586922</gtr:id><gtr:otherNames>Villani AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>eA23k547AvY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D18AA726-227A-4585-8E35-B0606A64B873</gtr:id><gtr:title>Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a32e5e38a8b83514d902fbe4626b80ee"><gtr:id>a32e5e38a8b83514d902fbe4626b80ee</gtr:id><gtr:otherNames>Wellcome Trust Case Control Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>JAR41cJCm2Q</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85B91B3A-0C48-40A8-A54F-FA3E2A578F95</gtr:id><gtr:title>Correction: changes to serum sample tube and processing methodology does not cause inter-individual variation in automated whole serum N-glycan profiling in health and disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be7f3c9c818fb8f7c8a3e8507c421eed"><gtr:id>be7f3c9c818fb8f7c8a3e8507c421eed</gtr:id><gtr:otherNames>Ventham NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58b95f2f4c7bb1.33080033</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15A04665-D1BD-46E6-9851-4440DD42FE28</gtr:id><gtr:title>Changes to serum sample tube and processing methodology does not cause Intra-Individual [corrected] variation in automated whole serum N-glycan profiling in health and disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be7f3c9c818fb8f7c8a3e8507c421eed"><gtr:id>be7f3c9c818fb8f7c8a3e8507c421eed</gtr:id><gtr:otherNames>Ventham NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58b95f2fdc86e1.37722175</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2744EF4-D966-4263-8CF4-5479FDDBE77E</gtr:id><gtr:title>Single nucleotide polymorphisms that increase expression of the guanosine triphosphatase RAC1 are associated with ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52c5be27aaf2a70d86136ab7214ebf96"><gtr:id>52c5be27aaf2a70d86136ab7214ebf96</gtr:id><gtr:otherNames>Muise AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>BFwhQib4RKv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D852923D-75CB-4A79-984D-184714C35CBD</gtr:id><gtr:title>Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease.</gtr:title><gtr:parentPublicationTitle>Journal of pediatric gastroenterology and nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58e9b7843c867fa71473bb98977691f6"><gtr:id>58e9b7843c867fa71473bb98977691f6</gtr:id><gtr:otherNames>Russell RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0277-2116</gtr:issn><gtr:outcomeId>54648c062f1125.25759238</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1AC2289-22CF-4595-B17A-E34BC4267938</gtr:id><gtr:title>Danish cohort of monozygotic inflammatory bowel disease twins: Clinical characteristics and inflammatory activity.</gtr:title><gtr:parentPublicationTitle>World journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e504e6f1ba46486879fb5b5cedf84836"><gtr:id>e504e6f1ba46486879fb5b5cedf84836</gtr:id><gtr:otherNames>Moller FT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1007-9327</gtr:issn><gtr:outcomeId>58b95f2d5cb1c0.79881372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8FBD75A-516F-43CD-AD7C-A958797EEA66</gtr:id><gtr:title>Nationwide linkage analysis in Scotland to assess mortality following hospital admission for Crohn's disease: 1998-2000.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>pm_15892_22_22070187</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27351BBE-3518-469A-B26A-71D9477C9CF8</gtr:id><gtr:title>Variation in ICOSLG influences Crohn's disease susceptibility.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>X8DpX18JEuU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>523DEFF7-725F-43FE-8789-D98183D19BE3</gtr:id><gtr:title>Meta-analysis and imputation refines the association of 15q25 with smoking quantity.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f08243406518279380370a3fd236f37"><gtr:id>4f08243406518279380370a3fd236f37</gtr:id><gtr:otherNames>Liu JZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>MrXP8LbMej3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55449EA5-E643-49F7-B9C8-D49307137F02</gtr:id><gtr:title>Genome-wide and fine-resolution association analysis of malaria in West Africa.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f21f1d98cd7f57fabc7b6af7b890e47"><gtr:id>5f21f1d98cd7f57fabc7b6af7b890e47</gtr:id><gtr:otherNames>Jallow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>bWdSFdEN5PP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABC7971E-4773-4A35-A3F0-1F92B3D33C8E</gtr:id><gtr:title>Genome-wide association study identifies eight loci associated with blood pressure.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15b00f9f5513473e8bd79455323c1869"><gtr:id>15b00f9f5513473e8bd79455323c1869</gtr:id><gtr:otherNames>Newton-Cheh C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>i65KQEkNbTC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDCD091B-9B02-4493-928F-7D24476F563C</gtr:id><gtr:title>Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>The Journal of pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9eeda35358bcc4dfe61af28779ec9474"><gtr:id>9eeda35358bcc4dfe61af28779ec9474</gtr:id><gtr:otherNames>Barclay AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3476</gtr:issn><gtr:outcomeId>CQ9fRzksXgm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7A47409-8E9E-4E9E-9B06-17ADA9EA420F</gtr:id><gtr:title>Rising incidence of pediatric inflammatory bowel disease in Scotland.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>545a52de5ef402.34204530</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E1E0B9C-A54D-4875-9B9B-4BC33535D4E9</gtr:id><gtr:title>Haplotype-tagging analysis of common variants of the IL23R gene demonstrates gene-wide extent of association with IBD.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f444492accbb6a473246d6fe44c8a127"><gtr:id>f444492accbb6a473246d6fe44c8a127</gtr:id><gtr:otherNames>Van Limbergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>pm_15892_22_23535247</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5694AB7B-09C0-4FC9-B0C4-C374BAB8982A</gtr:id><gtr:title>MicroRNAs: new players in IBD.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7cfe472cce65a6e4c1409d62261cbc1"><gtr:id>a7cfe472cce65a6e4c1409d62261cbc1</gtr:id><gtr:otherNames>Kalla R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>551048bcdb3910.90856244</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33749F5F-63DD-4A48-B59B-B5FC17AC2CA7</gtr:id><gtr:title>Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f444492accbb6a473246d6fe44c8a127"><gtr:id>f444492accbb6a473246d6fe44c8a127</gtr:id><gtr:otherNames>Van Limbergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>54648e55079dd7.66202065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C7E70A0-7F4F-4922-9621-DE0D53EC6F59</gtr:id><gtr:title>Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/370760c2b2beee5cc61a02c9e4c3e85c"><gtr:id>370760c2b2beee5cc61a02c9e4c3e85c</gtr:id><gtr:otherNames>Noble CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>D14VDuf6TmE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7703035C-F1E0-4793-AEE9-B8B0EB5E438E</gtr:id><gtr:title>Can Thiopurines Prevent Formation of Antibodies Against Tumor Necrosis Factor Antagonists After Failure of These Therapies?</gtr:title><gtr:parentPublicationTitle>Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28b1a25bedef401550366563cc3c49fc"><gtr:id>28b1a25bedef401550366563cc3c49fc</gtr:id><gtr:otherNames>Boyapati RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1542-3565</gtr:issn><gtr:outcomeId>58b95f2b78ce47.61996198</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C45CF18-75C4-4338-B8DB-1CA92FD2D202</gtr:id><gtr:title>Negligible impact of rare autoimmune-locus coding-region variants on missing heritability.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28d5e44cfd0fb461260062e89bab9868"><gtr:id>28d5e44cfd0fb461260062e89bab9868</gtr:id><gtr:otherNames>Hunt KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15892_22_23698362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E22D0CAD-7560-4F25-B30C-08FF925F60C7</gtr:id><gtr:title>NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52c5be27aaf2a70d86136ab7214ebf96"><gtr:id>52c5be27aaf2a70d86136ab7214ebf96</gtr:id><gtr:otherNames>Muise AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>545a46c09ad004.52449282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>214CB671-44B9-483D-B316-1D7C80A8363E</gtr:id><gtr:title>Biomarkers in Search of Precision Medicine in IBD.</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28b1a25bedef401550366563cc3c49fc"><gtr:id>28b1a25bedef401550366563cc3c49fc</gtr:id><gtr:otherNames>Boyapati RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>58b95f2c026cf6.54458369</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A9C4E3B-5DEF-44D7-91D4-87C2C52CB986</gtr:id><gtr:title>Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f08243406518279380370a3fd236f37"><gtr:id>4f08243406518279380370a3fd236f37</gtr:id><gtr:otherNames>Liu JZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58b98783bd4a65.18936381</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6517C6C3-DA6F-4B29-A869-10A33EE6F3B7</gtr:id><gtr:title>Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d48c2365018bf37692689d84ad467a48"><gtr:id>d48c2365018bf37692689d84ad467a48</gtr:id><gtr:otherNames>Beaudoin M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_15892_22_24068945</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB9156B9-F0D4-4493-BE6B-7517CAE6CA48</gtr:id><gtr:title>NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7db1b373f7864413af24edeb44e89bed"><gtr:id>7db1b373f7864413af24edeb44e89bed</gtr:id><gtr:otherNames>Schwerd T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>5a8e8fa4042559.49169605</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6F204D7-B8A6-4C38-824B-510508808E54</gtr:id><gtr:title>Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be7f3c9c818fb8f7c8a3e8507c421eed"><gtr:id>be7f3c9c818fb8f7c8a3e8507c421eed</gtr:id><gtr:otherNames>Ventham NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a8e92198e5c96.65334105</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4614A2E-6585-496A-A9E5-634F796FFDED</gtr:id><gtr:title>Therapeutic options in acute severe ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Expert review of gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33800cbdd8ec2b7e624dd14dad808264"><gtr:id>33800cbdd8ec2b7e624dd14dad808264</gtr:id><gtr:otherNames>Hare NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1747-4124</gtr:issn><gtr:outcomeId>it4REmLPQrU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>947FB2C3-700A-4317-9D86-9895FDA46732</gtr:id><gtr:title>Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history.</gtr:title><gtr:parentPublicationTitle>Expert review of gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd368253fec639b465fd164d29cb2ba"><gtr:id>2bd368253fec639b465fd164d29cb2ba</gtr:id><gtr:otherNames>Lees CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1747-4124</gtr:issn><gtr:outcomeId>PqgaULSxffD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83266B4A-26A6-43DD-B3F0-72ED0260FF3A</gtr:id><gtr:title>Mass spectrometry analysis of the oxidation states of the pro-oncogenic protein anterior gradient-2 reveals covalent dimerization via an intermolecular disulphide bond.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/498e5c5e03c2f41f7b91d5f863b1ad16"><gtr:id>498e5c5e03c2f41f7b91d5f863b1ad16</gtr:id><gtr:otherNames>Clarke DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>585d533206ddc6.93037980</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F67BFA9A-0854-48E0-93A7-DDDE5782887A</gtr:id><gtr:title>Anti-TNF therapy for paediatric IBD: the Scottish national experience.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c5840b49afd918f3f3f911a699aa139"><gtr:id>1c5840b49afd918f3f3f911a699aa139</gtr:id><gtr:otherNames>Cameron FL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>doi_55f984984bd46761</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83437B15-2C10-4E19-A5A6-20926858CF1C</gtr:id><gtr:title>Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28b1a25bedef401550366563cc3c49fc"><gtr:id>28b1a25bedef401550366563cc3c49fc</gtr:id><gtr:otherNames>Boyapati RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>58c132fae3bd01.51152525</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92FA3E36-3B10-4CDC-A83A-B2D3F334BC18</gtr:id><gtr:title>Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a32e5e38a8b83514d902fbe4626b80ee"><gtr:id>a32e5e38a8b83514d902fbe4626b80ee</gtr:id><gtr:otherNames>Wellcome Trust Case Control Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>PtUMbSvWPPY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61EE20C1-33A7-422B-90C0-603BF0FD58DB</gtr:id><gtr:title>Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia.</gtr:title><gtr:parentPublicationTitle>Archives of general psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c48199838cc2f29a1eac9e5f8f6b0422"><gtr:id>c48199838cc2f29a1eac9e5f8f6b0422</gtr:id><gtr:otherNames>Grozeva D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-990X</gtr:issn><gtr:outcomeId>KkCJE7YYw7b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0BF5B33-1CBC-4BDD-8B3C-562662D86388</gtr:id><gtr:title>Bayesian refinement of association signals for 14 loci in 3 common diseases.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a32e5e38a8b83514d902fbe4626b80ee"><gtr:id>a32e5e38a8b83514d902fbe4626b80ee</gtr:id><gtr:otherNames>Wellcome Trust Case Control Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_15892_22_23104008</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>352117C0-A547-43FC-BF58-D88D6F08D4EF</gtr:id><gtr:title>Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34b818d5cf371312cf412804af2f7353"><gtr:id>34b818d5cf371312cf412804af2f7353</gtr:id><gtr:otherNames>Nicholls RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>ePaaFtDq1TN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>825C6017-CE00-4CC9-9C49-900984AEDCF0</gtr:id><gtr:title>Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin D.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09cfc8db9d3df695e158267049a53fe6"><gtr:id>09cfc8db9d3df695e158267049a53fe6</gtr:id><gtr:otherNames>Flanagan PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>58b95f2f8eb030.25205860</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01C34D32-C1DF-480E-8DBB-0490A6A27404</gtr:id><gtr:title>Predicting the need for colectomy in severe ulcerative colitis: a critical appraisal of clinical parameters and currently available biomarkers.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4e64c34aaae304b77559843fb6dcff8"><gtr:id>a4e64c34aaae304b77559843fb6dcff8</gtr:id><gtr:otherNames>Travis S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>FTNa5Z8kbLx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAAEAE71-6676-4ABB-B1B7-4A304C6F73CE</gtr:id><gtr:title>Copy number variation of scavenger-receptor cysteine-rich domains within DMBT1 and Crohn's disease.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8572e735ea379400c17eb20c116ef05a"><gtr:id>8572e735ea379400c17eb20c116ef05a</gtr:id><gtr:otherNames>Polley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>58b95f2e776cc6.58148849</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1925416-B92E-4CFB-8404-438C6BCEE18A</gtr:id><gtr:title>Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43d0d23737bcf164813e93f774577d3e"><gtr:id>43d0d23737bcf164813e93f774577d3e</gtr:id><gtr:otherNames>UK IBD Genetics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>beJZ58q5Qjj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF03993C-18C1-4A16-BDAE-792F81619594</gtr:id><gtr:title>Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8e45c11ff8b196523502e41d8ce46cf"><gtr:id>c8e45c11ff8b196523502e41d8ce46cf</gtr:id><gtr:otherNames>Anderson CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>N6z2etrz5iU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F851E70-8617-4C04-869E-D3C047821B7E</gtr:id><gtr:title>TLE1 modifies the effects of NOD2 in the pathogenesis of Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8ba377304d5e7fd1f2b7d997300293a"><gtr:id>c8ba377304d5e7fd1f2b7d997300293a</gtr:id><gtr:otherNames>Nimmo ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>545a529824ae66.24153503</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC345D15-D8F7-4E09-92E8-C43DF1F1F45D</gtr:id><gtr:title>Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c601a805f173a4991f1b619667ca44c2"><gtr:id>c601a805f173a4991f1b619667ca44c2</gtr:id><gtr:otherNames>Dehghan A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1942-3268</gtr:issn><gtr:outcomeId>QhstBYADDqk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8196C011-2A2A-4DEA-A0E1-4FAD67AF0FF6</gtr:id><gtr:title>Autophagy: from basic science to clinical application.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f444492accbb6a473246d6fe44c8a127"><gtr:id>f444492accbb6a473246d6fe44c8a127</gtr:id><gtr:otherNames>Van Limbergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>sMDWG6BPA2d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2ABC6EFF-6E60-4AAC-977F-9C9E168ADBD0</gtr:id><gtr:title>Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial.</gtr:title><gtr:parentPublicationTitle>The lancet. Gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b286adc1a9b5cef514339bc18c7d9a29"><gtr:id>b286adc1a9b5cef514339bc18c7d9a29</gtr:id><gtr:otherNames>Lindsay JO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a8e90be126d84.73155277</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>234F0320-D677-4E82-9D75-B7C520B8C061</gtr:id><gtr:title>Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e2d0947beef3a4da746fc9d89cbb670"><gtr:id>0e2d0947beef3a4da746fc9d89cbb670</gtr:id><gtr:otherNames>Turner D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>5464c21c2ae6c3.05485653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1EEB3BE-ABE8-48F9-925E-5DBC129D9772</gtr:id><gtr:title>High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/906af871a1f703f6246584282b1313b8"><gtr:id>906af871a1f703f6246584282b1313b8</gtr:id><gtr:otherNames>Eyre S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_15892_22_23143596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05E9A481-221E-4E09-A411-7E7B1ACC593A</gtr:id><gtr:title>Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5b403a7f6ad6f739fef6c9fb0b8f1fd"><gtr:id>d5b403a7f6ad6f739fef6c9fb0b8f1fd</gtr:id><gtr:otherNames>Luo Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58b95f2aed3475.31291029</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC1BABFD-F54B-45CA-9DD3-83CC8506AF31</gtr:id><gtr:title>Editorial: what can be done when infliximab stops working in ulcerative colitis?</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28b1a25bedef401550366563cc3c49fc"><gtr:id>28b1a25bedef401550366563cc3c49fc</gtr:id><gtr:otherNames>Boyapati RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>58c132fb362a60.69731705</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E845C1DB-09C0-4105-B3EE-60FC4BA67D63</gtr:id><gtr:title>Sarcoidosis complicating treatment with natalizumab for Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bffe2c88e0743de298720c2901b77790"><gtr:id>bffe2c88e0743de298720c2901b77790</gtr:id><gtr:otherNames>Parisinos CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>UsakmkjgTXx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC7B4DC8-3271-4598-810C-BD190D8F17C7</gtr:id><gtr:title>A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bd098697bd70f44f21e158259d0b6f4"><gtr:id>1bd098697bd70f44f21e158259d0b6f4</gtr:id><gtr:otherNames>Rivas MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a8e933c5452b7.53754809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB63A045-BABA-407C-B3DA-3A3533DC5BC8</gtr:id><gtr:title>Common variants at five new loci associated with early-onset inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a4163f30dfab1ea4a2d31101fa14e36"><gtr:id>5a4163f30dfab1ea4a2d31101fa14e36</gtr:id><gtr:otherNames>Imielinski M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>SikJJuh5Wje</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36587A37-54EF-467F-9922-41E717FC74DE</gtr:id><gtr:title>Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28d5e44cfd0fb461260062e89bab9868"><gtr:id>28d5e44cfd0fb461260062e89bab9868</gtr:id><gtr:otherNames>Hunt KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_15892_22_22200769</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E883815-C9DB-45A9-9550-DBF4D6157619</gtr:id><gtr:title>Differences in the integrase and reverse transcriptase transmitted resistance patterns in Northern Poland.</gtr:title><gtr:parentPublicationTitle>Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2c4aab0d4afcc3e208206d4ba1780f8"><gtr:id>d2c4aab0d4afcc3e208206d4ba1780f8</gtr:id><gtr:otherNames>Parczewski M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1567-1348</gtr:issn><gtr:outcomeId>58b95f2ab0be53.90572890</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAC5CAE8-0023-4210-BFE7-4A2A19008F5C</gtr:id><gtr:title>Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c83ed689c5a5ce62539b156194e47f43"><gtr:id>c83ed689c5a5ce62539b156194e47f43</gtr:id><gtr:otherNames>Reilly MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>Ni7cU9suXYP</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800759</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>